Skip to content

Clinical trials

Thrombocytopenia trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thrombocytopenia Country / region: Netherlands Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20062
20091
20101
20112
20121
20132
20141
20182
20192
20201
20221
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Recruiting2
Terminated2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
Abbott Medical Devices2
CTI BioPharma2
GlaxoSmithKline2
Maastricht University Medical Center2
Sanquin Research & Blood Bank Divisions2
AstraZeneca1
Erasmus Medical Center1
Karyopharm Therapeutics Inc1
Leiden University Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thrombocytopenia19
Purpura, Thrombocytopenic, Idiopathic6
Hematologic Diseases5
Anemia4
Purpura4
Hemorrhage3
Myeloproliferative Disorders3
Primary Myelofibrosis3
Bone Marrow Diseases2
Coronary Artery Disease2

Trials

Showing 51 to 19 of 19. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.